KM Biologics commences clinical trial of COVID-19 vaccine candidate
The study is a combined Phase 1 and Phase 2 trial involving 210 subjects to test the vaccine’s safety and ability to trigger an…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.